Graphite Bio Statistics Share Statistics Graphite Bio has 58.24M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 58.24M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 2.38M Failed to Deliver (FTD) Shares 5 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 877.88K, so 0% of the outstanding
shares have been sold short.
Short Interest 877.88K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1.04
Valuation Ratios The PE ratio is -9.52 and the forward
PE ratio is -7.95.
Graphite Bio's PEG ratio is
0.11.
PE Ratio -9.52 Forward PE -7.95 PS Ratio 0 Forward PS n/a PB Ratio 2.32 P/FCF Ratio -7.91 PEG Ratio 0.11
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Graphite Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 20.36,
with a Debt / Equity ratio of 0.
Current Ratio 20.36 Quick Ratio 20.36 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-8.29M Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 1K Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -85.71% in the
last 52 weeks. The beta is 0.2, so Graphite Bio's
price volatility has been higher than the market average.
Beta 0.2 52-Week Price Change -85.71% 50-Day Moving Average 21.26 200-Day Moving Average 18.32 Relative Strength Index (RSI) 49.77 Average Volume (20 Days) 40,955
Income Statement
Revenue n/a Gross Profit n/a Operating Income -58.61M Net Income -49.77M EBITDA -58.61M EBIT n/a Earnings Per Share (EPS) -2.34
Full Income Statement Balance Sheet The company has 20.16M in cash and 814K in
debt, giving a net cash position of 19.34M.
Cash & Cash Equivalents 20.16M Total Debt 814K Net Cash 19.34M Retained Earnings n/a Total Assets 217.33M Working Capital 203.2M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -59.39M
and capital expenditures -468K, giving a free cash flow of -59.86M.
Operating Cash Flow -59.39M Capital Expenditures -468K Free Cash Flow -59.86M FCF Per Share -2.81
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields GRPH does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for GRPH.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 22, 2024. It was a
backward
split with a ratio of 1:7.
Last Split Date Mar 22, 2024 Split Type backward Split Ratio 1:7
Scores Altman Z-Score 10.07 Piotroski F-Score 3
